يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"self-controlled case-series (SCCS)"', وقت الاستعلام: 1.42s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: Sub Pharmacotherapy, Theoretical, Sub Clinical Pharmacy, Pharmacoepi, Pharmacoepidemiology and Clinical Pharmacology

    المصدر: Pharmacoepidemiology and Drug Safety, 25(Suppl. S1). John Wiley and Sons Ltd
    Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
    Consejería de Sanidad de la Comunidad de Madrid
    Pharmacoepidemiology and Drug Safety, 25(Suppl. S1), 79–87. John Wiley and Sons Ltd
    Pharmacoepidemiology and Drug Safety

    وصف الملف: image/pdf; application/pdf

  4. 4
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  5. 5

    المساهمون: Medical Informatics

    المصدر: Human Vaccines & Immunotherapeutics, 11(7), 1848-1852. Landes Bioscience
    Human Vaccines & Immunotherapeutics
    HUMAN VACCINES & IMMUNOTHERAPEUTICS
    r-FISABIO. Repositorio Institucional de Producción Científica
    instname
    r-FISABIO: Repositorio Institucional de Producción Científica
    Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

  6. 6
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  7. 7
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  8. 8
    كتاب

    لا يتم عرض هذه النتيجة على الضيوف.

  9. 9
  10. 10
    دورية أكاديمية

    المؤلفون: Requena G; Pharmacology Unit, Department of Biomedical Sciences, School of Medicine, University of Alcalá, Madrid, Spain., Logie J; Worldwide Epidemiology, GlaxoSmithKline, Research and Development, Uxbridge, Middlesex, UK., Martin E; BIFAP Research Unit, Spanish Agency of Medicines and Medical Devices, Madrid, Spain., Boudiaf N; Worldwide Epidemiology, GlaxoSmithKline, Research and Development, Uxbridge, Middlesex, UK., González González R; BIFAP Research Unit, Spanish Agency of Medicines and Medical Devices, Madrid, Spain., Huerta C; BIFAP Research Unit, Spanish Agency of Medicines and Medical Devices, Madrid, Spain., Alvarez A; BIFAP Research Unit, Spanish Agency of Medicines and Medical Devices, Madrid, Spain., Webb D; Worldwide Epidemiology, GlaxoSmithKline, Research and Development, Uxbridge, Middlesex, UK., Bate A; Epidemiology, Pfizer Ltd, Tadworth, UK., García Rodríguez LA; Spanish Center for Pharmacoepidemiological Research (CEIFE), Madrid, Spain., Reynolds R; Epidemiology, Pfizer Research and Development, New York, USA., Schlienger R; Global Clinical Epidemiology, Novartis Pharma AG, Basel, Switzerland., Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands., de Groot M; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands., Klungel OH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands., de Abajo F; Pharmacology Unit, Department of Biomedical Sciences, School of Medicine, University of Alcalá, Madrid, Spain.; Clinical Pharmacology Unit, University Hospital Príncipe de Asturias, Madrid, Spain., Douglas IJ; London School of Hygiene and Tropical Medicine (LSHTM), London, UK.

    المصدر: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2016 Mar; Vol. 25 Suppl 1, pp. 79-87. Date of Electronic Publication: 2015 Jun 26.

    نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

    بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE